Perigon Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Perigon Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$241K	Sell	16,628 -1,932	-10%	-$26.1K	﹤0.01%	1256
2026 Q1	$257K	Buy	18,560 +849	+5%	+$11.8K	﹤0.01%	1080
2025 Q4	$249K	Buy	+17,711	New	+$248K	﹤0.01%	1117
2017 Q1	–	Sell	-2,545	Closed	-$22K	–	686
2016 Q4	$22K	Buy	2,545 +1,365	+116%	+$12.7K	﹤0.01%	455
2016 Q3	$11K	Buy	+1,180	New	+$11.3K	﹤0.01%	471

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Perigon Wealth Management's RDY Position: Q2 2026 in Review

Perigon Wealth Management reduced its Dr. Reddy's Laboratories (RDY) stake by 10% in Q2 2026, selling an estimated $26.1K and leaving 16,628 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Perigon Wealth Management first reported a position in RDY in Q3 2016 and has held it in 5 quarters since. The position peaked at $257K in Q1 2026. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Perigon Wealth Management held 16,628 shares of Dr. Reddy's Laboratories worth $241K as of Q2 2026.
Perigon Wealth Management sold 1,932 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $26.1K.
Dr. Reddy's Laboratories made up ﹤0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #1256 holding.
Perigon Wealth Management first reported a position in Dr. Reddy's Laboratories in Q3 2016 and has held it in 5 quarters since.
Perigon Wealth Management's Dr. Reddy's Laboratories position peaked at $257K in Q1 2026.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.